| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/18/2001 | WO2001004157A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 01/18/2001 | WO2001004156A1 Peptides that lower blood glucose levels |
| 01/18/2001 | WO2001004155A2 Feline interleukin-12 as an immune stimulant |
| 01/18/2001 | WO2001004154A1 Method for purifying granulocyte colony stimulating factor |
| 01/18/2001 | WO2001004153A1 Death effector domain of mammalian apoptosis mediator, fadd, inducing bacterial cell death |
| 01/18/2001 | WO2001004152A1 Mucin |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004150A2 Neisseria meningitidis compounds and anti-infection applications thereof |
| 01/18/2001 | WO2001004149A1 Antigenic epitopes and mosaic polypeptides of hepatitis c virus proteins |
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004145A2 Glutx polypeptide family and nucleic acids encoding same |
| 01/18/2001 | WO2001004144A2 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 01/18/2001 | WO2001004143A2 Prostase vaccine |
| 01/18/2001 | WO2001004142A2 Neurotransmitter transporter |
| 01/18/2001 | WO2001004141A2 Seripancrin |
| 01/18/2001 | WO2001004140A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | WO2001004139A2 Human axor29 receptor |
| 01/18/2001 | WO2001004138A1 Dsra protein and polynucleotides encoding the same |
| 01/18/2001 | WO2001004137A1 Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene |
| 01/18/2001 | WO2001004133A1 Human eag2 |
| 01/18/2001 | WO2001003744A2 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of the c, d or v genes |
| 01/18/2001 | WO2001003740A1 Serine protease inhibitor |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003731A1 Dim mutants of mycobacteria and uses thereof |
| 01/18/2001 | WO2001003724A1 Therapeutic uses of bpi protein products for inhibiting h+/k+ atpase activity |
| 01/18/2001 | WO2001003723A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | WO2001003722A1 Cftr polypeptides, fragments thereof and methods of use to overcome biosynthetic misprocessing |
| 01/18/2001 | WO2001003721A1 Improved assays for detecting human immunodeficiency virus infection |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | WO2001003717A2 Methods of inducing cell death |
| 01/18/2001 | WO2001003680A2 Compounds for inhibiting diseases and preparing cells for transplantation |
| 01/18/2001 | WO2000071714A3 Methods of reducing factor viii clearance and compositions therefor |
| 01/18/2001 | WO2000068383A3 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 01/18/2001 | WO2000066755A3 Pesticidal fusions |
| 01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000061752A3 Modified complement system regulators |
| 01/18/2001 | WO2000060078A3 Latheo encodes a subunit of the origin of recognition complex |
| 01/18/2001 | WO2000060050A3 Recombinant influenza viruses for vaccines and gene therapy |
| 01/18/2001 | WO2000058488A3 Delivery of functional protein sequences by translocating polypeptides |
| 01/18/2001 | WO2000055193A3 Human dan/cerberus related protein 6 (dcr6) |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000053760A3 Method of preventing the death of retinal neurons and treating ocular diseases |
| 01/18/2001 | WO2000053213A3 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
| 01/18/2001 | WO2000051631A3 Pegylated alpha interferon for hiv therapy |
| 01/18/2001 | WO2000043782A3 Removal of prions from blood, plasma and other liquids |
| 01/18/2001 | WO2000039304A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/18/2001 | WO2000037634A3 Novel polypeptides and nucleic acids encoding same |
| 01/18/2001 | WO2000032825A3 Development of anti-microbial agents based on bacteriophage genomics |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/18/2001 | WO1999051756A3 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 01/18/2001 | DE19933288A1 Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung Structural protein of adeno-associated virus with altered antigenicity, its preparation and use |
| 01/18/2001 | DE19933237A1 Verfahren zur Bestimmung der Proliferationsaktivität von Zellen A method for determining the proliferative activity of cells |
| 01/18/2001 | DE19933089A1 Mittel zur Gewerbsregeneration Means for commercial regeneration |
| 01/18/2001 | DE19932782A1 Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung A method for the chromatographic fractionation of plasma or serum preparations thus obtained and the use thereof |
| 01/18/2001 | DE19932688A1 Design von Beta-Faltblatt-Proteinen mit spezifischen Bindungseigenschaften Design of beta-sheet proteins with specific binding properties |
| 01/18/2001 | DE19930676A1 Verfahren zur Stabilisierung von Proteinen in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln A process for the stabilization of proteins in complex mixtures with storage thereof in aqueous solvents |
| 01/18/2001 | DE19929488A1 Treatment of inflammation, autoimmune disease and tumors by suppressing activation mediated by the lymphotoxin beta-receptor |
| 01/18/2001 | DE19906921A1 New neuronal cell survival factor, useful for treatment and diagnosis of neuronal diseases, e.g. Alzheimer's disease |
| 01/18/2001 | CA2801979A1 Antigenic meningococcal peptides |
| 01/18/2001 | CA2680437A1 Peptides that lower blood glucose levels |
| 01/18/2001 | CA2385102A1 Expression vectors and methods |
| 01/18/2001 | CA2383496A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | CA2379373A1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and .beta.1 integrins |
| 01/18/2001 | CA2379362A1 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | CA2379345A1 T-cell receptor .gamma. alternate reading frame protein, (tarp) and uses thereof |
| 01/18/2001 | CA2379235A1 Antigenic epitopes and mosaic polypeptides of hepatitis c virus proteins |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2379059A1 Mosaic infectious bursal disease virus vaccines |
| 01/18/2001 | CA2379010A1 Methods of inducing cell death |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378985A1 Atherosclerosis-associated genes |
| 01/18/2001 | CA2378875A1 Novel neisseria meningitidis compounds and anti-infection applications thereof |
| 01/18/2001 | CA2378846A1 Prostase vaccine |
| 01/18/2001 | CA2378796A1 Seripancrin |
| 01/18/2001 | CA2378786A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378661A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | CA2378653A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | CA2378610A1 Human eag2 |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378566A1 Method for purifying granulocyte colony stimulating factor |
| 01/18/2001 | CA2378552A1 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 01/18/2001 | CA2378515A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | CA2378501A1 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 01/18/2001 | CA2378485A1 Proliferation differentiation factor |
| 01/18/2001 | CA2378452A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | CA2378407A1 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | CA2378240A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | CA2378179A1 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | CA2378097A1 Induction of a th1-like response in vitro |
| 01/18/2001 | CA2377677A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | CA2375628A1 Compounds for inhibiting diseases and preparing cells for transplantation |
| 01/18/2001 | CA2373534A1 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/17/2001 | EP1069187A1 Mosaic Infectious Bursal Disease Virus vaccines |
| 01/17/2001 | EP1069184A1 Human anion transporter gene implicated in Salla disease and lysosomal sialic acid transport |
| 01/17/2001 | EP1069137A1 Peptides having thrombospondin-like activity and their therapeutic use |
| 01/17/2001 | EP1069136A1 Method for the recombinant production of ribonucleoproteins |